Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The glycosylation of the circulating immunoglobulin-gamma (IgG) antibody molecules changes in rheumatoid arthritis. The extent of the changes correlates with the disease severity and reverses in remission. We demonstrate here that the alteration in glycosylation associated with rheumatoid arthritis can create a new mode for the interaction of IgG with complement through binding to the collagenous lectin mannose-binding protein (MBP). Rheumatoid arthritis is associated with a marked increases in IgG glycoforms that lack galactose (referred to as G0 glycoforms) in the Fc region of the molecule and that terminate in N-acetyl glucosamine (GlcNAc). We show, using nuclear magnetic resonance (NMR) and X-ray data, that these terminal GlcNAc residues become accessible for MBP binding. We further demonstrate that multiple presentation of IgG-G0 glycoforms to MBP results in activation of the complement. This suggests that a contribution to the chronic inflammation of the synovial membrane could arise from the localization of the IgG-G0 glycoforms in the affected joint and from resulting activation of complement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Modified Spin-Echo Method for Measuring Nuclear Relaxation Times
Meiboom, S., & Gill, D. (1958) · Review of Scientific Instruments · doi:10.1063/1.1716296 · Cited by 6,022
The hydrolysis of rabbit γ-globulin and antibodies with crystalline papain
Porter, R. R. (1959) · Biochemical Journal · doi:10.1042/bj0730119 · Cited by 2,308
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Self-citationStructure of a C-type mannose-binding protein complexed with an oligosaccharide
Weis, W. I., Drickamer, K., & Hendrickson, W. A. (1992) · Nature · doi:10.1038/360127a0 · Cited by 885
The binding site for C1q on IgG
Duncan, A. R., & Winter, G. (1988) · Nature · doi:10.1038/332738a0 · Cited by 569
Drickamer, K., Dordal, M. S., & Reynolds, L. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62698-0 · Cited by 429
Serum lectin with known structure activates complement through the classical pathway.
Ikeda, K., Sannoh, T., Kawasaki, N., Kawasaki, T., & Yamashina, I. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47587-4 · Cited by 424
Trimeric structure of a C-type mannose-binding protein
Weis, W. I., & Drickamer, K. (1994) · Structure · doi:10.1016/s0969-2126(94)00124-3 · Cited by 307
Research works printed but not linked: 2
- Chang, S.-C. Altered Glycosylation in Immunoglobulin G and Its Fragments in Rheumatoid Arthritis. thesis, Oxford (1993).
- Parekh, R.B. A Study of the Structure and Biosynthesis of N-linked Oligosaccharides and of their Involvement in Certain Diseases. thesis, Oxford Univ.(1987).
Cited by
Items 401–500 of 844
Limnell, V., Aittoniemi, J., Vaarala, O., Lehtimäki, T. J., Laine, S., Virtanen, V., Palosuo, T., & Miettinen, A. (2002) · Cardiology · doi:10.1159/000066313 · Cited by 32
“MBL is capable of binding to certain phospholipids, oligosaccharide structures and glycosylated IgG [ ,”
Complement Proteins as Soluble Pattern Recognition Receptors for Pathogenic Viruses
Murugaiah, V., Varghese, P. M., Beirag, N., Cordova, S. D., Sim, R. B., & Kishore, U. (2021) · Viruses · doi:10.3390/v13050824 · Cited by 31
Self-citationTerai, I., Kobayashi, K., Vaerman, J., & Mafune, N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1737 · Cited by 31
“These phenomena have been thought to be due to differences in carbohydrate presentation between IgG-G0 in RA patients and that in normal serum (12).”
BackgroundMethodInfluentialAltered serumN-glycomics in chronic hepatitis B patients
Gui, H., Gao, C., Wang, H., Liu, X., Xie, Q., Dewaele, S., Wang, L., Zhuang, H., Contreras, R., Libert, C., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02170.x · Cited by 31
“The mechanisms by which agalactosyl IgG might be pathogenic in autoimmune disease remain unclear but it has been suggested that these isoforms self-aggregate in the joints of RA patients (35) or interact with mannose-binding protein (36), thereby fixing the complement and triggering inflammation.”
BackgroundSquare-wave voltammetry assays for glycoproteins on nanoporous gold
Pandey, B., Bhattarai, J. K., Pornsuriyasak, P., Fujikawa, K., Catania, R., Demchenko, A. V., & Stine, K. J. (2014) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2014.01.009 · Cited by 31
Abnormal galactosylation of immunoglobulin G in cerebrospinal fluid of multiple sclerosis patients
Decker, Y., Schomburg, R., Németh, E., Vitkin, A., Fousse, M., Liu, Y., & Fassbender, K. C. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516631036 · Cited by 31
Martin, K., Talukder, R., Hay, F. C., & Axford, J. S. (2001) · PubMed · Cited by 31
Cheng, H. D., Stöckmann, H., Adamczyk, B., McManus, C. A., Ercan, A., Holm, I. A., Rudd, P. M., Ackerman, M. E., & Nigrovic, P. A. (2017) · Glycobiology · doi:10.1093/glycob/cwx082 · Cited by 30
“ERA, enthesitis-related arthritis; ILAR, International League of Associations for Rheumatology; JIA, Juvenile idiopathic arthritis; JPsA, juvenile psoriatic arthritis; MBL, mannose-binding lectin; MFI, median fluorescence intensity; RA, rheumatoid arthritis; UPLC, ultra-performance liquid chromatography.”
BackgroundSelf-citationMannan-binding lectin (MBL) in women with tumours of the reproductive system
Świerzko, A. S., Florczak, K., Cedzyński, M., Szemraj, J., Wydra, D. G., Bąk‐Romaniszyn, L., Emerich, J., & Sułowska, Z. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0250-7 · Cited by 30
“MBL was also detected in Xuid from the small intestine of AIDS patients infected with Cryptosporidium parvum [20], in synovial Xuid of patients with rheumatoid arthritis [31], and in nasopha-”
BackgroundXu, P., Gou, S., Yang, X.-W., Cui, Z., Jia, X., Chen, M., & Zhao, M. (2012) · BMC Immunology · doi:10.1186/1471-2172-13-10 · Cited by 30
“Of note, 15-20% of human IgG molecules bear N-linked oligosaccharides in the fragment antigen binding (Fab) part, depending on the type of variable chain amino acids [9-12].”
BackgroundMultiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation
Ercan, A., Barnes, M., Hazen, M. M., Tory, H. O., Henderson, L. A., Dedeoğlu, F., Fuhlbrigge, R. C., Grom, A. A., Holm, I. A., Kellogg, M. D., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34507 · Cited by 30
Self-citationMembranous nephropathy: A fairy tale for immunopathologists, nephrologists and patients
Ronco, P. M., & Dêbiec, H. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.07.003 · Cited by 30
“Because MBL has been shown to bind N-linked sugars on IgG that lack terminal galactose (39), it was suggested that the anti-PLA2R1 IgG4”
BackgroundN-Glycosylation of Serum IgG and Total Glycoproteins in MAN1B1 Deficiency
Saldova, R., Stöckmann, H., O’Flaherty, R., Lefeber, D. J., Jaeken, J., & Rudd, P. M. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00709 · Cited by 30
Self-citationThe Complement System in Innate Immunity
Mayilyan, K. R., Kang, Y., Dodds, A. W., & Sim, R. B. (2007) · Nucleic acids and molecular biology · doi:10.1007/978-3-540-73930-2_10 · Cited by 30
“It also interacts with the glycans of the common glycosylation variant of human IgG, named IgG-G0 ( Malhotra et al. 1995 ), and with some IgA forms (Roos et al. 2001) and with glycans on mouse IgM (McMullen et al. 2006).”
BackgroundSelf-citationStefanović, G., Marković, D. C., Ilić, V. L., Brajović, G., Petrovic, S., & Milošević‐Jovčić, N. (2006) · Journal of Periodontology · doi:10.1902/jop.2006.060049 · Cited by 30
Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis
Colomb, F., Giron, L. B., Trbojević‐Akmačić, I., Lauc, G., & Abdel‐Mohsen, M. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00433-w · Cited by 29
Lourido, L., Blanco, F. J., & Ruíz‐Romero, C. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1321481 · Cited by 29
Plasma N-glycome composition associates with chronic low back pain
Trbojević‐Akmačić, I., Vučković, F., Vilaj, M. Ć., Skelin, A., Karssen, L. C., Krištić, J., Jurić, J., Momčilović, A., Šimunović, J., Mangino, M., et al. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.07.003 · Cited by 29
“Additionally it has been shown that high-mannose glycans increase serum clearence of IgG [57] and can initiate complement pathway by binding to mannose-binding lectin [58].”
BackgroundChanges in Serum N -Glycosylation Profiles: Functional Significance and Potential for Diagnostics
Mariño, K. V., Saldova, R., Adamczyk, B., & Rudd, P. M. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849732765-00057 · Cited by 30
Self-citationAnalysis of different glycosylation states in IgG subclasses
Keusch, J. J., Levy, Y. M., Shoenfeld, Y., & Youinou, P. (1996) · Clinica Chimica Acta · doi:10.1016/0009-8981(96)06326-7 · Cited by 29
Heterogeneity of IgG Glycosylation in Adult Periodontal Disease
Novak, J., Tomana, M., Shah, G. R., Brown, R., & Mestecky, J. (2005) · Journal of Dental Research · doi:10.1177/154405910508401005 · Cited by 29
“, 1994): Galactose-deficient IgG binds to the mannan-binding lectin and thus activates the complement cascade by the lectin pathway (Malhotra et al., 1995).”
BackgroundInfluentialIgG Glycosylation: Biomarker, Functional Modulator, and Structural Component
Radovani, B., & Nimmerjahn, F. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2400447 · Cited by 28
Buhre, J. S., Becker, M., & Ehlers, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1006939 · Cited by 28
Østergaard, J. A., Thiel, S., Hovind, P. H., Holt, C. B., Parving, H., Flyvbjerg, A., Rossing, P. R., & Hansen, T. K. (2014) · Diabetologia · doi:10.1007/s00125-014-3332-7 · Cited by 28
Triguero, A., Cabrera, G., Rodríguez, M., Soto, J., Zamora, Y., Pérez, M., Wormald, M. R., & Cremata, J. A. (2011) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2011.00638.x · Cited by 28
Self-citationIslam, S., Moinuddin, M., Mir, A. R., Raghav, A., Habib, S., Alam, K., & Ali, A. (2017) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2017.1365770 · Cited by 28
“Both glycation and oxidation-mediated protein damage has been reported with pathological implications in various disorders (Aksenov, Aksenova, Butterfield, Geddes, & Markesbery, 2001; Kalousova, Skrha, & Zima, 2002; Lemarechal et al., 2006; Malhotra et al., 1995; Salahuddin, Rabbani, & Khan, 2014; Watala et al., 2005).”
BackgroundEstablishing a Case for Anti-complement Therapy in Membranous Nephropathy
Ayoub, I. M., Shapiro, J. P., Song, H., Zhang, X. L., Parikh, S. M., Almaani, S. J., Madhavan, S. M., Brodsky, S. V., Satoskar, A. A., Bott, C., et al. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.11.032 · Cited by 28
Cabrera, G., Cremata, J. A., Valdés, R., García, R., González, Y., Montesino, R., Gómez, H., & González, M. (2005) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20040032 · Cited by 28
Galactosylation of IgG1 modulates FcγRIIB-mediated inhibition of murine autoimmune hemolytic anemia
Yamada, K. D., Ito, K., Furukawa, J., Nakata, J., Alvarez, M., Verbeek, J. S., Shinohara, Y., & Izui, S. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.09.001 · Cited by 26
Ercan, A., Cui, J., Hazen, M. M., Batliwalla, F., Royle, L., Rudd, P. M., Coblyn, J. S., Shadick, N. A., Weinblatt, M. E., Gregersen, P. K., et al. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3756 · Cited by 27
“This conformation enables binding of mannose-binding lectin, resulting in an enhanced propensity to fix complement, and animal studies suggest that G0 IgG may be especially arthritogenic [9-11].”
BackgroundSelf-citationJEDDI, P. A., Bodman-Smith, K. B., Lund, T., Lydyard, P. M., Mengle-Gaw, L. J., Isenberg, D. A., Youinou, P., & Delves, P. (1996) · Immunology · doi:10.1046/j.1365-2567.1996.474593.x · Cited by 27
McGuire, J. M., Douglas, M. G., & Smith, K. D. (1996) · Carbohydrate Research · doi:10.1016/s0008-6215(96)91015-0 · Cited by 27
Ito, K., Furukawa, J., Yamada, K., Tran, N. L., Shinohara, Y., & Izui, S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302488 · Cited by 26
“Previous in vitro studies claimed that agalactosylated IgG could enhance the activation of complement through its interaction withMBL, thereby promoting its pathogenic potential (22).”
BackgroundDetection of an Autologous Ligand for Mannan‐Binding Lectin on Human B Lymphocytes
Downing, I., MacDonald, S. L., Turner, M. L., & Kilpatrick, D. C. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2005.01693.x · Cited by 26
IgA Nephropathy and Related Diseases
Novák, J., Raška, M., Mestecky, J. F., & Julian, B. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00105-1 · Cited by 26
Scott, D. A., Wang, M., Grauzam, S. E., Pippin, S., Black, A. P., Angel, P. M., Drake, R. R., Castellino, S., Kono, Y., Rockey, D. C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.797460 · Cited by 25
Mizuochi, T., Pastore, Y. D., Shikata, K., Kuroki, A., Kikuchi, S., Fulpius, T., Nakata, M., Fossati‐Jimack, L., Reininger, L., Matsushita, M., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3537 · Cited by 25
Mannose-binding lectin does not explain the course and outcome of pregnancy in rheumatoid arthritis
van de Geijn, F. E., de Man, Y. A., Wuhrer, M., Willemsen, S. P., Deelder, A. M., Hazes, J. M., & Dolhain, R. J. E. M. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3231 · Cited by 25
“It has been shown in vitro that MBL can bind to pathogenic agalactosyl IgG [3].”
Relevance of the lectin pathway of complement in rheumatic diseases
Boldt, A. B. W., Goeldner, I., & Messias-Reason, I. (2012) · Advances in clinical chemistry · doi:10.1016/b978-0-12-394317-0.00012-1 · Cited by 25
Panda, S., Zhang, J., Yang, L., Anand, G. S., & Ding, J. L. (2014) · Scientific Reports · doi:10.1038/srep03675 · Cited by 25
Effects of statins on the immunoglobulin G glycome
Keser, T., Vučković, F., Barrios, C., Zierer, J., Wahl, A., Akinkuolie, A. O., Štambuk, J., Nakić, N., Štambuk, T., Periša, J., et al. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.02.029 · Cited by 24
Osses, I. S. E., Messias-Reason, I., & Ramirez, M. I. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/675898 · Cited by 24
“SinceMBL also binds to IgM, IgA, and IgG antibodies [58–60], both pathways (classical and lectin) could be synergistically activated in the presence of specific antibodies and in chronic infections.”
BackgroundReversibility of Membrane N-Glycome of HeLa Cells upon Treatment with Epigenetic Inhibitors
Horvat, T., Deželjin, M., Redžić, I., Barišić, D., Bosnar, M. H., Lauc, G., & Zoldoš, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054672 · Cited by 24
“Here, the attachment of a single additional monosaccharide can lead to various outcomes, including conversion of IgG from pro-inflammatory into an anti-inflammatory agent [1] or activation of pathways implicated in various inflammatory diseases [2,3].”
BackgroundSaevarsdóttir, S., Steinsson, K., Ludviksson, B. R., Gröndal, G., & Valdimarsson, H. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03349.x · Cited by 24
Mannan binding protein in sera positive for rheumatoid factor
Kilpatrick, D. C. (1997) · Rheumatology · doi:10.1093/rheumatology/36.2.207 · Cited by 24
“Recently, it has been shown that MBP can bind to agalactosyl IgG, but not native IgG, and can induce complement activation by interacting with the former [8].”
BackgroundRheumatoid arthritis sera antibodies to citrullinated collagen type II bind to joint cartilage
Li, Q., Li, Y., Liang, B., Xu, R. X., Xu, B., Lönnblom, E., Feng, H., Bai, J., Stawikowska, R., Ge, C., et al. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02945-0 · Cited by 23
Human anti‐immunoglobulin antibodies interfering in immunometric assays
Bjerner, J. (2005) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510510025818 · Cited by 23
“MBL has a structure similar to the C1q.”
BackgroundInfluentialWagner, É., Platt, J. L., Howell, D. N., Marsh, H. C., & Frank, M. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.6.3549 · Cited by 23
The Structure of a Human Rheumatoid Factor Bound to IgG Fc
Sutton, B. J., Corper, A. L., Sohi, M. K., Jefferis, R., Beale, D., & Taussig, M. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5383-0_4 · Cited by 23
The Role of Complement in the Pathogenesis and Treatment of Myasthenia Gravis
Salazar, A., Mokhtari, S., Peguero, E. N., & Jaffer, M. (2025) · Cells · doi:10.3390/cells14100739 · Cited by 22
“Aberrant galactose residues appear to inhibit or negate the activation of the lectin pathway when compared with IgG molecules containing other carbohydrate residues [33].”
The antibody paradigm: present and future development as a scaffold for biopharmaceutical drugs
Jefferis, R. (2009) · Biotechnology and Genetic Engineering Reviews · doi:10.5661/bger-26-1 · Cited by 22
“A degalactosylated form of IgG1 was shown to bind and activate the MBL/MASP complex and initiate a consequent cascade (Malhotra et al., 1995).”
BackgroundDolman, K. M., Brouwer, N., Frakking, F. N. J., Flatø, B., Tak, P. P., Kuijpers, T. W., Førre, Ø. T., & Smerdel, A. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2386 · Cited by 22
“Binding of MBL to agalactosyl IgG immune complexes may result in local complement activation and subsequent increased inflammation and thus active disease, whereas this is absent in the presence of very low levels of MBL [40].”
BackgroundGlycobiology and Medicine: An Introduction
Axford, J. S. (1997) · Journal of the Royal Society of Medicine · doi:10.1177/014107689709000508 · Cited by 22
The effect of mannan-binding lectin on opsonophagocytosis of Neisseria meningitidis
Drogari‐Apiranthitou, M., Fijen, C. A. P., Thiel, S., Platonov, A. E., Jensen, L., Dankert, J., & Kuijper, E. J. (1997) · Immunopharmacology · doi:10.1016/s0162-3109(97)00081-7 · Cited by 22
Cruz, H., Peixoto, C., Nimtz, M., Alves, P. M., Dias, E. M., Moreira, J. L., & Carrondo, M. J. T. (2000) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(20000720)69:2<129::aid-bit2>3.0.co;2-5 · Cited by 22
Ohsawa, I., Ohi, H., Tamano, M., Endo, M., Fujita, T., Satomura, A., Hidaka, M., Fuke, Y., Matsushita, M., & Fujita, T. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5098 · Cited by 21
Jacobsen, S., Garred, P., MADSEN, H. O., Heegaard, N. H. H., Hetland, M. L., Stengaard‐Pedersen, K., Junker, P., Lottenburger, T., Ellingsen, T., Andersen, L. S., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080846 · Cited by 21
Troelsen, L. N., Garred, P., Christiansen, B., Torp-Pedersen, C. T., & Jacobsen, S. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100158 · Cited by 21
De Novo Ceramide Synthesis Is Required for N-Linked Glycosylation in Plasma Cells
Goldfinger, M., Laviad, E. L., Hadar, R., Shmuel, M., Dagan, A., Park, H., Merrill, A. H., Ringel, I., Futerman, A. H., & Tirosh, B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802990 · Cited by 21
“The SDSPAGE profiles of these pathologic Ig molecules is highly reminiscent of what we observed for FB1-treated B cells (35, 36), strengthening the notion of a potential link between the two phenomena.”
BackgroundKanoh, Y., Ohara, T., Mashiko, T., Abe, T., Masuda, N., & Akahoshi, T. (2006) · PubMed · Cited by 21
Saevarsdóttir, S., Kristjansdottir, H., Gröndal, G., Víkingsdóttir, T., Steinsson, K., & Valdimarsson, H. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.046086 · Cited by 21
Surfactant protein A binds to IgG and enhances phagocytosis of IgG-opsonized erythrocytes
Lin, P. M., & Wright, J. R. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00188.2006 · Cited by 21
“(12) noted mannan-binding protein bound to an unusual glycosylated form of IgG, but not to the native form, which is consistent with the possibility that collectin interactions with aberrant forms of IgG may occur via the collectin CRD.”
BackgroundDe Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20
Xie, Q., Wang, S., Bian, G., Zhan, F., Ji-kui, X., & Li, J. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.07.043 · Cited by 20
“MBL can induce complement activation by interacting with IgG0, and the MBL- IgG0 complex resembles in the joint fluid of RA patients [24].”
BackgroundMeng, X., Wang, B., Xu, X., Song, M., Hou, H., Wang, W., & Wang, Y. (2022) · The EPMA Journal · doi:10.1007/s13167-022-00278-1 · Cited by 21
Hyposialylation Must Be Considered to Develop Future Therapies in Autoimmune Diseases
Bordron, A., Morel, M., Bagacean, C., Dueymes, M., Pochard, P., Harduin‐Lepers, A., Jamin, C., & Pers, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073402 · Cited by 20
Human Immunoglobulin Glycosylation and the Lectin Pathway of Complement Activation
Arnold, J. N., Royle, L., Dwek, R. A., Rudd, P. M., & Sim, R. B. (2005) · Advances in experimental medicine and biology · doi:10.1007/0-387-25515-x_9 · Cited by 20
“In human serum only IgG-G0 and polymeric and dimeric IgA have been shown to bind MBL and initiate the lectin pathway of complement (Malhotra et al., 1995; Roos et al., 2001).”
BackgroundInfluentialSelf-citationAdvances in analytical methodologies to guide bioprocess engineering for bio-therapeutics
Saldova, R., Kilcoyne, M., Stöckmann, H., Millán‐Martín, S., Lewis, A. M., Tuite, C. M. E., Gerlach, J. Q., Berre, M. L., Borys, M., Li, Z. J., et al. (2016) · Methods · doi:10.1016/j.ymeth.2016.11.002 · Cited by 20
Self-citationIvanova, M., Rui-qing, J., Matsushita, M., Ogawa, T., Kawai, S., Ochiai, N., Shivarov, V. S., Maruya, E., & Saji, H. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.09.007 · Cited by 20
Genetic Studies of Human Lupus in Families
Arnett, F. C. (2000) · International Reviews of Immunology · doi:10.3109/08830180009055501 · Cited by 20
Goodarzi, M. T., Axford, J. S., Varanasi, S. S., Alavi, A., Cunnane, G., FitzGerald, O., & Turner, G. A. (1998) · Glycoconjugate Journal · doi:10.1023/a:1006920007227 · Cited by 20
The N-Glycosylation of Total Plasma Proteins and IgG in Atrial Fibrillation
Plavša, B., Szavits-Nossan, J., Blivajs, A., Rapčan, B., Radovani, B., Šesto, I., Štambuk, K., Mustapić, V., Đerek, L., Rudan, D., et al. (2023) · Biomolecules · doi:10.3390/biom13040605 · Cited by 19
“In rheumatoid arthritis, this was shown to increase the activation of the complement via the MBL pathway [48].”
BackgroundZlatina, K., & Galuska, S. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.753294 · Cited by 19
“observed that agalactosyl N-glycans on IgG are also recognized by MBP, leading to an activation of the lectin complement pathway (12) (Figure 5A).”
BackgroundBaudino, L., Nimmerjahn, F., Shinohara, Y., Furukawa, J., Petry, F., Verbeek, J. S., Nishimura, S., Ravetch, J. V., & Izui, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4107 · Cited by 19
“Furthermore, it has been reported that galactose-less IgG can more efficiently activate complement through the lectin pathway in vitro, in which mannose-binding lectin (MBL) can interact with N-acetylglucosamines exposed as a result of absence of galactosylation (G0 in Fig. 4) ( 33 ).”
BackgroundC1q and Mannose-Binding Lectin
Reid, K. B. M. (1998) · CRC Press eBooks · doi:10.1201/b14212-4 · Cited by 19
Glycosylation Analysis of Therapeutic Glycoproteins Produced in CHO Cells
Carillo, S., Mittermayr, S., Farrell, A., Albrecht, S., & Bones, J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6972-2_15 · Cited by 19
Yamaguchi, Y., Takahashi, N., & Kato, K. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00072-6 · Cited by 19
Computational tools for predicting and controlling the glycosylation of biopharmaceuticals
Kontoravdi, C., & Jimenez del Val, I. (2018) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2018.08.007 · Cited by 18
Membranous nephropathy in the kidney allograft
Filippone, E. J., & Farber, J. L. (2016) · Clinical Transplantation · doi:10.1111/ctr.12847 · Cited by 18
Kavur, M. M., Lauc, G., & Pezer, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00086-9 · Cited by 19
Stang, M.-B. L., Gleeson, P. J., Daha, M. R., Monteiro, R. C., & van Kooten, C. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.09.010 · Cited by 18
Štambuk, J., Vučković, F., Habazin, S., Hanić, M., Novokmet, M., Nikolaus, S., Tran, F., Schreiber, S., Franke, A., Rosenstiel, P. C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158473 · Cited by 18
“Proposed mechanisms include activation of complement via the alternative pathway, or via the lectin pathway after binding to mannose-binding lectin [25,26].”
BackgroundRonco, P. M., Vivarelli, M., Ayalon, R., & Dêbiec, H. (2022) · Springer eBooks · doi:10.1007/978-3-030-52719-8_94 · Cited by 18
Marchi, L. F., Paoliello-Paschoalato, A. B., de Oliveira, R. D. R., Azzolini, A. E. C. S., Kabeya, L. M., Donadi, E. A., & Lucisano-Valim, Y. M. (2018) · Rheumatology International · doi:10.1007/s00296-018-3997-1 · Cited by 18
Lauc, G., & Zoldoš, V. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.03.059 · Cited by 18
Glycomic Signatures on Serum IgGs for Prediction of Postvaccination Response
Wang, J., Guan, W., Yau, L., Gao, W., Zhan, Y., Liu, L., Yang, Z., & Jiang, Z. (2015) · Scientific Reports · doi:10.1038/srep07648 · Cited by 17
O’Regan, N. L., Steinfelder, S., Schwedler, C., Rao, G. B., Srikantam, A., Blanchard, V., & Hartmann, S. (2014) · Parasite Immunology · doi:10.1111/pim.12137 · Cited by 18
“glycan)(43, 44) to induce pro-inflammatory responses.”
Glycoproteomic Survey of Mammillaria gracillis Tissues Grown in Vitro
Balen, B., Krsnik‐Rasol, M., Zamfir, A. D., Milošević, J., Vakhrushev, S. Y., & Peter‐Katalinić, J. (2006) · Journal of Proteome Research · doi:10.1021/pr0600327 · Cited by 18
Brajović, G., Stefanović, G., Ilić, V. L., Petrovic, S., Stefanović, N., Nikolić‐Jakoba, N., & Milošević‐Jovčić, N. (2010) · Journal of Periodontology · doi:10.1902/jop.2010.100053 · Cited by 17
Fletcher, E. A. K., Eltahir, M., Lindqvist, F., Rieth, J., Törnqvist, G., Leja-Jarblad, J., & Mangsbo, S. M. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.10.021 · Cited by 17
“Another possible explanation is complement activation via the lectin pathway [39], something that requires further evaluation.”
BackgroundAbnormal IgG galactosylation in MRL‐lpr/lpr mice: Pathogenic role in the development of arthritis
Kuroda, Y., Nakata, M., Hirose, S., Shirai, T., Iwamoto, M., Izui, S., Kojima, N., & Mizuochi, T. (2001) · Pathology International · doi:10.1046/j.1440-1827.2001.01306.x · Cited by 17
Revisiting the immunopathology of congenital disorders of glycosylation: an updated review
Pascoal, C., Francisco, R., Mexia, P., Pereira, B. L., Granjo, P., Coelho, H., Barbosa, M., Ferreira, V. D. R., & Videira, P. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1350101 · Cited by 16
High-throughput N-glycan analysis in aging and inflammaging: State of the art and future directions
Cindrić, A., Pribić, T., & Lauc, G. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2024.101890 · Cited by 18
Humoral signatures of Caspr2-antibody spectrum disorder track with clinical phenotypes and outcomes
Terroba-Navajas, P., Spatola, M., Chuquisana, O., Joubert, B., de Vries, J. M., Dik, A., Marmolejo, L., Jönsson, F., Lauc, G., Kovac, S., et al. (2024) · Med · doi:10.1016/j.medj.2024.09.004 · Cited by 16
Involvement of mannose-binding lectin in the pathogenesis of Kawasaki disease-like murine vasculitis
Nakamura, A., Okigaki, M., Miura, N. N., Suzuki, C., Ohno, N., Kametani, F., & Hamaoka, K. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.03.019 · Cited by 16
Chemouny, J., Hurtado-Nédelec, M., Flament, H., Mkaddem, S. B., Daugas, É., Vrtovsnik, F., Berthelot, L., & Monteiro, R. C. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv335 · Cited by 16
Rodríguez‐Zhurbenko, N., Rabade‐Chediak, M., Bedoya, D. M., Griñán, T., & Hernández, A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12827 · Cited by 16
IgG and IgM glycosylation patterns in patients undergoing image-guided tumor ablation
Breen, L. D., Pučić‐Baković, M., Vučković, F., Reiding, K. R., Trbojević‐Akmačić, I., Gajdošik, M. Š., Cook, M. I., Lopez, M. J., Wuhrer, M., Camara, L., et al. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.01.011 · Cited by 18
Huang, T., Chen, X., Gu, H., Zhao, C., Liu, X., Yan, M., Deng, X., Zhang, Z., & Gu, J. (2016) · Oncotarget · doi:10.18632/oncotarget.9085 · Cited by 16
“com/oncotarget contribute to a new mode of interaction of IgG with complement [33].”
BackgroundVarga, L. Á., Szilágyi, K., Lőrincz, Z., Berrens, L., Thiel, S., Závodszky, P., Daha, M. R., Thielens, N. M., Arlaud, G. J., Nagy, K. L., et al. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00023-3 · Cited by 16
Metadata
- Authors
- Malhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A., & Sim, R. B.
- Affiliations
- University of Oxford (GB)
- Venue
- Nature Medicine
- Published
- 1995-03
- Volume
- 1
- Issue
- 3
- Pages
- 237-243
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2053863608
- Cited by
- 786
- References
- 33
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 21 · 2023: 17 · 2022: 34 · 2021: 29 · 2020: 25 · 2019: 32 · 2018: 35 · 2017: 34 · 2016: 32 · 2015: 27 · 2014: 36 · 2013: 36 · 2012: 29
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- rheumatoid arthritis, IgG glycosylation, mannose-binding protein, complement activation, Fc fragment, N-acetylglucosamine, synovitis, chronic inflammation
- MeSH terms
- Arthritis, Rheumatoid, Carbohydrate Sequence, Carrier Proteins, Complement Activation, Computer Simulation, Glycosylation, Humans, Immunoglobulin G, Immunoglobulin Fc Fragments, Models, Molecular, Molecular Sequence Data, Magnetic Resonance Spectroscopy, Synovial Fluid, Mannose-Binding Lectins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.